glp-1 inyectable receptor agonists, including semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound), are being recognized for benefits beyond blood sugar control and weight management. New real-world evidence suggests they may also play a role in GLP-1 No Longer on FDA's

This complementary action makes dual therapy an attractive option for patients requiring more aggressive glucose management

Active ingredients per 5.4ml sachet: L-Glutathione (Setria) (reduced form) 450mg Essential phospholipids (from soy lecithin) 1,000mg Phosphatidylcholine 500mg

A large number of acquired nevi and the presence of clinically atypical nevi each represents a marker of increased risk for development of melanoma, and patients with either trait should be followed with periodic total body skin examinations beginning around puberty

Digital solutions for rare diseases in global health

But you may be able to control it with medicine, gentle skin care and avoiding things that cause flare-ups